Immunotherapy as an advance in cancer medicine - Innovations Report
Annkristin HEINE | Medical Doctor | Professor | University of Bonn - Medical Center, Bonn | Haematology Oncology | Research profile
Krebszentrum CIO Bonn - Ich bin Prof. Annkristin Heine | Facebook
Long-term survival correlates with immunological responses in renal cell carcinoma patients treated with mRNA-based immunotherap
The VEGF-Receptor Inhibitor Axitinib Impairs Dendritic Cell Phenotype and Function | PLOS ONE
Detection of Damaged DNA Bases by DNA Glycosylase Enzymes | Biochemistry
Pacritinib protects dendritic cells more efficiently than ruxolitinib - Experimental Hematology
Volume 21, Issue 3, Pages (October 2017) - ppt download
Annkristin HEINE | Medical Doctor | Professor | University of Bonn - Medical Center, Bonn | Haematology Oncology | Research profile
Researchers release the brakes on the immune | EurekAlert!
Dexamethasone induced inhibition of Dectin-1 activation of antigen presenting cells is mediated via STAT-3 and NF-κB signaling pathways | Scientific Reports
Team | IMMEI
Ann-Kristin Müller – Stellvertretende Niederlassungsleiterin – Heine + Beisswenger Gruppe | LinkedIn
Team | IMMEI
Total marrow irradiation versus total body irradiation using intensity-modulated helical tomotherapy,Journal of Cancer Research and Clinical Oncology - X-MOL
AG Heine - Hämatologie und Onkologie des Universitätsklinikums Bonn
CIO Bonn - Lymphomzentrum
Auszeichnung für herausragende Krebsforscher – Innovations Report
Team | IMMEI
Tückischen Blutkrebs effektiv bekämpfen - Centrum für Integrierte Onkologie
Frontiers | Red blood cell transfusions impact response rates to immunotherapy in patients with solid malignant tumors
